| Literature DB >> 32868763 |
Minji Lee1, Eunmin Lee2, Seong Kyu Han3, Yoon Ha Choi2, Dong-Il Kwon1, Hyobeen Choi3, Kwanghwan Lee3, Eun Seo Park2, Min-Seok Rha4, Dong Jin Joo5,6, Eui-Cheol Shin4, Sanguk Kim7, Jong Kyoung Kim8, You Jeong Lee9.
Abstract
Invariant natural killer T (iNKT), mucosal-associated invariant T (MAIT), and γδ T cells are innate T cells that acquire memory phenotype in the thymus and share similar biological characteristics. However, how their effector differentiation is developmentally regulated is still unclear. Here, we identify analogous effector subsets of these three innate T cell types in the thymus that share transcriptional profiles. Using single-cell RNA sequencing, we show that iNKT, MAIT and γδ T cells mature via shared, branched differentiation rather than linear maturation or TCR-mediated instruction. Simultaneous TCR clonotyping analysis reveals that thymic maturation of all three types is accompanied by clonal selection and expansion. Analyses of mice deficient of TBET, GATA3 or RORγt and additional in vivo experiments corroborate the predicted differentiation paths, while human innate T cells from liver samples display similar features. Collectively, our data indicate that innate T cells share effector differentiation processes in the thymus.Entities:
Mesh:
Year: 2020 PMID: 32868763 PMCID: PMC7459300 DOI: 10.1038/s41467-020-18155-8
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Innate T cells have analogous effector subsets.
a Single-cell suspensions of 7-week-old BALB/c thymocytes were stained with PBS57 loaded CD1d tetramer, 5-OP-RU loaded MR1 tetramer, and anti-TCRγδ (GL3), and enriched for iNKT, MAIT, and γδ T cells respectively using MACS beads. Representative dot plots are shown and numbers indicate frequencies of cells in adjacent gates. Representative results of at least 10 independent experiments are shown. b Heat map shows log2 values of mean fluorescence intensities of cells expressing indicated markers analyzed by flow cytometry. Hierarchical clustering was made by Pearson correlation. Representative results of three independent experiments are shown. c Heat maps show expression patterns of cytokines, receptors, and transcription factors mapped to overexpressed genes in each Tγδ subset. Expression patterns were quantified by column Z-scores of regularized log2-value of read counts. d Principal component analysis (PCA) plot shows subset distribution of Tγδ subsets. Each dot represents a biological replicate. e PCA plot using 120 functional genes including cytokines, receptors, and transcription factors shows subset distribution of iNKT and γδ T cells. Each dot represents a biological replicate. f MAIT cells were enriched from Tcrd KO mice and analyzed for their subset profiles. Graph shows statistical analysis of number of MAIT subsets in indicated mice (n = 5 except analysis for CD24hi stage 1 MAIT cells (n = 3), right). Results are pooled from three independent experiment and numbers indicate frequencies of cells in adjacent gates (left). Each dot represents an individual mouse. Data are presented as mean ± SD. Unpaired two-tailed t-test was used. *P < 0.05, **P < 0.01. Source data are provided as a Source Data file.
Fig. 2scRNA-seq defines developmental intermediates of innate T cells.
a Experimental scheme of scRNA-seq analysis is shown. b Uniform manifold approximation and projection (UMAP) plot shows all innate T cells (8239 cells) derived from two pooled replicates. Each cell type was labeled with indicated colors. c UMAP plots show the expression levels of indicated marker genes. Colors represent the log2-transformed normalized counts of genes. d Combined UMAPs with each type of innate T cell divided into cell clusters (colored): iNKT (3285 cells, left), MAIT (2287 cells, middle), and γδ T cells (2667 cells, right). Cell clusters were annotated as analyzed in Supplementary Figs. 8–10.
Fig. 3Trajectory analysis predicts precursors of MAIT and γδ T cells.
a, b Far left: UMAP plots of MAIT (a) and γδ T cells (b) show schematic representation of trajectories. Left to far right: t-SNE plots of MAIT (a) and γδ T cells (b) colored by cell clusters (left), Palantir pseudotime (right), and Palantir branching probabilities (far right). c Projections of the MAIT clusters to iNKT clusters by scamp-cluster. d Heat maps illustrate log2-transformed fold change of frequency of each TRGV/TRDV gene pair in a given cell cluster with respect to all γδ T cells.
Fig. 4Innate T cells are clonally selected during development.
a Graphs show the distribution of CDR3α/γ (top) and CDR3β/δ (bottom) lengths of iNKT, MAIT, and γδ T cells, presented as the number of cells for each length. Canonical (top left, orange) and non-canonical (top right, turquoise) TCRα are shown together in iNKT and MAIT cells. The relative amino acid composition is shown for the most common length by using the WebLogo application (hydrophilic, blue; neutral, green; and hydrophobic, black). b Bar plots show the ordered number of cells for each clonotype repeated 3 or more in iNKT (left), MAIT (middle), and γδ T cells (right), colored by each subset (iNKT) or their UMAP regions (MAIT and γδ T). Each bar represents an individual clonotype from Supplementary data 2. c Normalized number of clonotypes (y-axis) within each type of innate T cells (colored lines) plotted over the number of cells having the identical clonotype. d Line plots show the Shannon equitability indexes of clonotypes for the indicated subset of cell cluster in iNKT (left), MAIT (middle), and γδ T cells (right). e t-SNE plot of γδ T cells colored by cells having the most abundant single clonotype from Supplementary data 2. f Graph shows percentage of cells having non-canonical TCRα subchain for each subset of iNKT. g Venn diagram shows the non-canonical TCRα and/or non-oligoclonal TCRβ usage of MAIT cells. Numbers indicate number of cells with each combination. Graphs show distribution of total cells or MAITs with non-canonical TCRα or non-canonical TCRα except 89 cells in Venn diagram in each MAIT cluster. Numbers in parentheses indicate total number of cells analyzed in each graph. Source data are provided as a Source Data file.
Fig. 5Lineage differentiation into Tγδ17 cells is flexible.
a Single-cell suspensions of BALB/c thymocytes were enriched for γδ T cells using MACS beads and analyzed for the expression of indicated markers. Representative data of three independent experiments are shown. b Four different subsets of γδ T cells were sorted as indicated (left) and performed fetal thymic organ culture (FTOC) for 7 days (middle). Graph shows the frequencies of CD24−RORγt+ cells after culture for 7 days (right, n = 3). Results from three independent sets of experiments are shown. c–e Thymi from adult B6 WT (n = 4) and Vγ4/6−/− (n = 6) (c) or 7-day-old BALB/c WT (n = 3) and BALB/c Rorc−/− (RorcEGFP/EGFP, n = 3) (d, e) mice were analyzed for the development of indicated γδ T subsets using flow cytometry. Representative dot plots are shown and graph shows statistical comparisons. Results are from two independent sets of experiments. Pie charts show mean frequencies of each subset among Tγδ17 cells (c) from adult B6 WT (n = 4) and Vγ4/6−/− (n = 5) and Tγδ1 (d) cells from BALB/c WT (n = 3) and 7 day-old BALB/c Rorc−/− (n = 3). Numbers indicate frequencies of cells in adjacent gates. Data are presented as mean ± SD. Unpaired two-tailed t-test was used. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, NS not significant (P > 0.05). Source data are provided as a Source Data file.
Fig. 6γδ T and MAIT cells develop via lineage differentiation process.
a Thymocytes from Cd4Cre (WT, n = 7) or Cd4Cre Gata3f/f (conditional KO (cKO), n = 4) mice were enriched for γδ T cells using MACS beads and analyzed for their subset frequencies amongst total γδ T cells (left). Graph shows statistical analysis (right). Representative data of two independent sets of experiment are shown. b MAIT cells were enriched from total thymocytes of WT (n = 5) or Gata3 cKO (n = 4) mice and compared for their absolute numbers. Representative dot plots (left) and statistical comparison is shown (right). Representative results from two independent sets of experiments are shown. c, d Single-cell suspensions of thymocytes from WT (n = 5) or TBET-deficient mice (n = 5) were enriched for γδ T (c) and MAIT (d) cells using MACS beads and analyzed for their subset development. Representative dot plots are from three independent experiments (left) and graph shows statistical analysis of three independent sets of experiment (right). Numbers indicate frequencies of cells in adjacent gates. Data are presented as mean ± SD. Unpaired two-tailed t-test was used. *P < 0.05, **P < 0.01, ***P < 0.001. NS not significant (P > 0.05). Source data are provided as a Source Data file.
Fig. 7Human and mouse innate T cells have analogous subsets.
a Human mononuclear cells obtained from liver perfusion fluid were stained with the indicated markers. Representative dot plots (left) show frequencies of iNKT (left), MAIT (middle), and γδ T cells (right) amongst total mononuclear cells. Representative FACS plots are from seven independent experiments and graph shows statistical analysis of their frequencies using pooled data (n = 4 for NKT cell analysis, n = 6 for MAIT cell analysis, n = 4 for γδ T cell analysis). b Total γδ T cells from (a) were stained with the indicated anti-TCR antibodies and representative FACS plots are from three independent experiments (left) and graph shows pooled results of their frequencies with statistical analysis (right, n = 5 except Vδ2+Vγ9+ cell analysis (n = 4)). c Indicated cells were stimulated with PMA and ionomycin, and intracellularly stained with the anti-cytokine antibodies. Representative dot plots are shown from three independent experiments. Numbers indicated frequencies of cells in adjacent gates or each quadrant. Data are presented as mean ± SD. Unpaired two-tailed t-test was used. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NS not significant (P > 0.05). Source data are provided as a Source Data file.
List of antibodies and reagents.
| Anti-CD3ε APC-Cy7 (clone 145-2C11) (1/200) | TONBO | 25-0031-U100 |
| Anti-CD4 BUV395 (clone GK1.5) (1/300) | BD Biosciences | 563,790 |
| Anti-CD4 BV510 (clone RM4-5) (1/200) | BD Biosciences | 563,106 |
| Anti-CD8α BV650 (clone 53-6.7) (1/300) | BD Biosciences | 563,234 |
| Anti-CD19 PE-Cy7 (clone 1D3) (1/400) | BD Biosciences | 552,854 |
| Anti-CD24 BV605 (clone M1/69) (1/1000) | Biolegend | 101,827 |
| Anti-CD24 FITC (clone M1/69) (1/700) | BD Biosciences | 553,261 |
| Anti-CD24 PE/Cy7 (clone M1/69) (1/800) | Biolegend | 101,821 |
| Anti-CD25 APC (clone PC61) (1/800) | Biolegend | 102,012 |
| Anti-CD27 PerCP-eFluor710 (clone LG.GF9) (1/200) | Thermo Fisher Scientific | 46-0271-82 |
| Anti-CD44 PE (clone IM7) (1/300) | Biolegend | 103,008 |
| Anti-CD44 redFluor710 (clone IM7) (1/300) | TONBO | 80-0441-U100 |
| Anti-CD45R/B220 BV711 (clone RA3-6B2) (1/300) | BD Bioscience | 563,892 |
| Anti-CD122 FITC (clone TM-BETA 1) (1/100) | BD Bioscience | 553,361 |
| Anti-CD122 PE (clone TM-b1 [TM-beta1]) (1/100) | Thermo Fisher Scientific | 12-1222-81 |
| Anti-CD183 (CXCR3) PE-Cy7 (clone CXCR3-173) (1/100) | Biolegend | 126,516 |
| Anti-CD186 (CXCR6) BV421 (clone SA051D1) (1/150) | Biolegend | 151,109 |
| Anti-CD196 (CCR6) BV421 (clone 29-2L17) (1/100) | Biolegend | 129,828 |
| Anti-CD279 (PD-1) APC (clone J43) (1/400) | BD Bioscience | 562,671 |
| Anti-IL-25R (IL17RB) Alexa Fluor647 (clone 9B10) (1/200) | Biolegend | 146,304 |
| Anti-IL-25R (IL17RB) PE (clone MUNC33) (1/100) | Thermo Fisher Scientific | 12-7361-80 |
| Anti-γδ T-Cell Receptor BV421 (clone GL3) (1/200) | BD Bioscience | 562,892 |
| Anti-γδ T-Cell Receptor PE (clone GL3) (1/100) | BD Bioscience | 553,178 |
| Anti-γδ T-Cell Receptor PE-CF594 (clone GL3) (1/300) | BD Bioscience | 563,532 |
| Anti-Vγ1.1 (Heilig and Tonegawa’s system: Vγ1) TCR BV421 (clone 2.11)(1/300) | BD Bioscience | 566,308 |
| Anti-Vγ1.1 + Vγ1.2 (Heilig and Tonegawa’s system: Vγ1 + Vγ2) TCR PE (clone 4B2.9) | Biolegend | 142,704 |
| Anti-Vγ2 (Heilig and Tonegawa’s system: Vγ4) TCR BV786 (clone UC3-10A6) (1/300) | BD Bioscience | 742,313 |
| Anti-Vγ3 (Heilig and Tonegawa’s system: Vγ5) TCR BV510 (clone 536) (1/200) | BD Bioscience | 743,239 |
| Anti-Vγ5/Vδ1+ and Vγ6/Vδ1+ (Heilig and Tonegawa’s system: Vγ5Vδ1+ and Vγ6Vδ1+) TCR rat IgM antibody (clone 17D1) | kindly provided by Dr. Robert Tigelaar | |
| Anti- Vγ7 TCR Biotinylated (clone F2.67) (1/600) | kindly provided by Dr. Pablo Pereira | |
| Anti-TCRβ chain (clone H57-597) (1/200) | BD Bioscience | 560,656 |
| Anti-Vδ 6.3/2 TCR BV711 (clone 8F4H7B7) (1/100) | BD Bioscience | 744,476 |
| Purified CD16/32 (clone 93) (1/200) | Biolegend | 101,302 |
| Anti-EOMES eFluor 450 (clone Dan11mag) (1/100) | Thermo Fisher Scientific | 48-4875-82 |
| Anti-IFN-γ PE-CF594 (clone XMG1.2) (1/200) | BD Bioscience | 562,303 |
| Anti-IL-4-Alexa647 (clone 11B11) (1/100) | Biolegend | 504,110 |
| Anti-IL-4 BV421 (clone 11B11) (1/50) | Biolegend | 504,119 |
| Anti-Ki-67 FITC (clone SolA15) (1/600) | Thermo Fisher Scientific | 11-5698-82 |
| Anti-IL-17A BV650 (clone TC11-18H10) (1/200) | BD Bioscience | 564,170 |
| Anti-PLZF Alexa Fluor647 (clone R17-809) (1/200) | BD Bioscience | 563,490 |
| Anti-PLZF PE-CF594 (clone R17-809) (1/400) | BD Bioscience | 565,738 |
| Anti-RORγt PerCP-Cy5.5 (clone Q31-378) (1/200) | BD Bioscience | 562,683 |
| Anti-RORγt PE-CF594 (clone Q31-378) (1/300) | BD Bioscience | 562,684 |
| Anti-T-bet PE-Cy7 (clone eBio4B10) (1/200) | Thermo Fisher Scientific | 25-5825-82 |
| Anti-rat IgM FITC (clone MRM-47) (1/300) | Biolegend | 408,905 |
| Streptavidin APC-Cy7 (1/400) | BD Bioscience | 554,063 |
| Streptavidin PE | BD Bioscience | 554,061 |
| Streptavidin-R-Phycoerythrin | ProZyme | PJRS25 |
| Anti-PE MicroBeads Ultrapure | Miltenyi Biotec | 130-105-639 |
| Anti-Human CD2 FITC (clone RPA-2.10) (1/50) | BD Bioscience | 555,326 |
| Anti-CD3 BUV395 (clone UCHT1) (1/300) | BD Bioscience | 563,546 |
| Anti-CD3 Alexa Fluor594 (clone UCHT1) (1/300) | Biolegend | 300,446 |
| Anti-CD4 APC/Cy7 (clone OKT4) (1/300) | Biolegend | 317,418 |
| Anti-CD8α Alexa Fluor700 (clone RPA-T8) (1/300) | Biolegend | 301,028 |
| Anti-CD19 V500 (clone HIB19) (1/300) | BD Bioscience | 561,121 |
| Anti-CD45RA BV650 (clone HI100) (1/300) | BD Bioscience | 563,963 |
| Anti-CD45RO BV711 (clone UCHL1) (1/300) | BD Bioscience | 563,722 |
| Anti-CD161 Alexa Fluor488 (clone HP-3G10) (1/25) | Biolegend | 339,924 |
| Anti-TCR Vα7.2 BV785 (clone 3C10) (1/25) | Biolegend | 351,722 |
| Anti-TCR γ/δ PerCP/Cy5.5 (clone B1) (1/25) | Biolegend | 331,224 |
| Anti-TCR Vγ9 BV421 (clone B3) (1/50) | BD Bioscience | 744,034 |
| Anti-TCR δ (TCR Vδ1-Jδ2) FITC (clone TS-1) (1/50) | Thermo Fisher Scientific | TCR2055 |
| Anti-TCR Vδ2 FITC (clone B6) (1/50) | Biolegend | 331,406 |
| Anti-IFN-γ BUV395 (clone B27) (1/25) | BD Bioscience | 563,563 |
| Anti-IL-4 BV605 (clone MP4-25D2) (1/25) | Biolegend | 500,827 |
| Anti-IL-17A APC (clone eBio64DEC17) (1/25) | Thermo Fisher Scientific | 17-7179-42 |
| Anti-T-bet PE-Cy7 (clone eBio4B10) (1:100) | Thermo Fisher Scientific | 25-5825-82 |
| Anti-PLZF Alexa Fluor647 (clone R17-809) (1/100) | BD Bioscience | 563,490 |
| Anti-RORγt PE (clone Q21-559) (1/20) | BD Bioscience | 563,081 |